The Changing Approach to Breast Cancer Treatment

When 31-year-old Riya (name changed), who was recently married, was diagnosed with early-stage breast cancer, her immediate worry was whether aggressive treatments like chemotherapy would affect her chances of pregnancy. While chemotherapy can play an important role in reducing the risk of cancer returning, its potential effects on fertility made the treatment decision particularly significant for her.For Riya, a recurrence risk prediction test, which indicates the likelihood of cancer returning after treatment, helped bring greater clarity to the decision. Her test results showed a low risk of recurrence, meaning the likelihood of her cancer returning was very low. Based on the findings and her oncologist’s assessment, chemotherapy was left out of her treatment plan. She underwent surgery and radiation, had a child the following year and later completed five years of hormone therapy.Riya’s experience reflects a larger shift in breast cancer treatment.